VanEck’s mission is to offer investors forward-looking, intelligently designed investment strategies that take advantage of targeted market opportunities. Founded in 1955, the firm is a pioneer in global investing with a history of placing clients’ interests first in all market environments.

Link to important disclosures.

Featured Research

Investment Outlook: What to Expect for the Rest of 2017

In this series, we discuss the decline and rebound of the commodity market, how the commodity market has affected emerging markets, and why negative interest rates might not be an ideal scenario for the US.

Global Outperformance and U.S. M&A Persist

US Stocks have performed well since Donald Trump’s inauguration. Many tailwinds drove markets to record levels.

Time to Rethink the Role of Emerging Market Bonds

In this series, we advance the case for investing in emerging markets bonds and identify some of the potential opportunities the asset class may offer in today’s market environment. 

Will Muni Bonds Experience the January Effect in 2017?

Are muni bonds going to experience the January Effect this year? We think so given what we believe is a unique environment. 

Strong Year for Gold Despite Post-Election Stress

In this series, we’ll discuss how gold has been prematurely halted due to extreme economic optimism after Trump’s victory. 

Is It Time to Be Opportunistic in Emerging Market Bonds?

Despite recent choppy waters in emerging markets, upside may be found in emerging market bonds. 

Moats React Strongly in November

Morningstar’s index tracking “moat” companies outperformed the general markets in November. Here’s why.

Gold Suffers as Irrationality Trumps Reality

The markets have reacted enthusiastically to Trump’s victory. Will this rally last, and is it based on reality?

What a Trump Presidency Means for Municipal Bonds

How will Trump’s policies affect municipal bond yields and the preferential tax treatment they enjoy?

Moats React Strongly in November

Here’s how Morningstar’s Moat indices performed in November.

Trump Uncertainty Could Be ‘Huge’ for Gold

Trump’s presidential victory and other global macro factors may provide strong support for gold prices.

Yield Curve Suggests Targeted Opportunity in Municipal Bonds

Municipal bonds have historically functioned as havens for tax-free returns. While municipal bond prices have fallen as of late, targeted opportunity remains in the asset class.

How Emerging Market Bond Credit Ratings Affect Returns

How do bond ratings affect yields in emerging markets? “Fallen Angel” bonds could be a source of untapped potential.

‘Moativated Investing’: A Big League Batting Average

Moat investing, as originally defined by Warren Buffett, could provide strong performance to your portfolio. Read on to learn about an ETF that gives broad exposure to a variety of Moat companies.

Is Emerging Market Debt Teeming with Yield Opportunities?

In this video series, Fran Rodilosso of VanEck discusses the opportunities currently present in emerging markets debt and the pros and cons of the different ways one can get exposure to this asset class.

Why Emerging Market Bonds Continue to Rally

Emerging markets performed well through the end of the third quarter. What are some reasons for the strong performance of this asset class, and what can we expect in the near term?

‘Moativated’ Investing: History of Outperformance

Could investing in “moat”  companies benefit your portfolio? Read on to learn more about what defines such companies and how you can access them.

Currencies: Why Look to Real Effective Exchange Rates?

Investors often consider exchange rates when evaluating investments in foreign markets. The real effective exchange rate, which factors in purchasing power of currency pairs, should also be examined.

Gold Bull Market Lost Some Shine but Is Still Healthy

Gold prices have been affected as of late by macroeconomic events and adjustments to the mining process. However, gold continues to function as a hedge against market turmoil.

VanEck Launches Two New Intermediate-Term Municipal Bond Funds

As returns from equities grow harder to extract, investors are turning to fixed income. VanEck discusses 2 new ETFs that hold intermediate-term municipal bond funds.

China: A $12 Trillion Economy You Shouldn’t Ignore

Although China’s economy has not posted the dazzling growth figures that investors have come to expect, the world’s most populous nation is still an important region to those looking for emerging markets exposure.

Politics Aside, Generic Drugs Are Key to the Drug Price Debate

Both Hillary Clinton and Donald Trump have defined views of health care and how to make it affordable for Americans. Generic drugs can can keep patients’ wallets a little fuller without compromising efficacy of treatment.

Introduction to Emerging Market Investment-Grade Bonds

Investing in emerging market debt doesn’t always have to be highly risky. VanEck’s Francis Rodilosso discusses emerging market investment-grade bonds.

Gold Consolidates Amid Late Summer Doldrums

Gold prices have begun to tick upwards after three years of underperformance. What could keep gold on its current trajectory or derail it?

What’s behind the Huge Inflows into Emerging Markets Debt?

Emerging Markets bond ETFs have seen record flows in 2016. What’s responsible for the apparent surge in popularity?

Hone In on Income, Not Financials

Why are preferred securities in non-Financial firms garnering interest in the investment community?

Quality Can Be Rewarding in Emerging Markets Bonds

Emerging market bonds have their inherent risks, but may be an attractive investment this year.

Investment Demand Sustaining Gold’s Run

Although gold’s (GLD) recent rise has been aided by tailwinds like slower global growth, the UK’s Brexit vote to exit the European Union, and lower returns from bonds and equities, movement in the second half will likely be driven by favorable seasonal factors.

Rate Expectations Drive Emerging Market Debt Rally

Global emerging markets debt, both hard and local currency, rebounded strongly in June after a significant retracement in May.

Investment-Grade Emerging Markets: Higher Yield, Balanced Risk

Emerging market corporate investment grade bonds provide higher yields versus U.S. corporate investment grade bonds, allowing for additional income potential without additional credit risks.

Gold Bull Market Gains Momentum

Gold has been in the midst of a bull market. What are some contributors to its current resurgence?

Fallen Angels Boosted by Bond Buyback Premiums

Fallen angel bonds—high-yield bonds originally issued with investment grade credit ratings—are generally known for offering potential value. Bond buybacks, however, are another potential source of value.

Why Own Fallen Angel Bonds

In this series, VanEck responds to our questions and looks at how fallen angel bonds have provided attractive relative income without an unsavory level of risk.

Attractive Yields and Value in High Yield Emerging Markets Bonds

High yield emerging market bonds offer attractive yields and opportunities for value investors.

Moat Investing: Why Spring Takeover Bids Are a Boon

The concept of an economic moat refers to how likely a company is to keep competitors at bay for an extended period of time. Simply put, moat investing comes down to identifying companies that are able to stay one step ahead of the competition. Economic moats are often part of the strategic rationale for M&A transactions and post-acquisition success can be an important factor in moat ratings.

What Do Fallen Angel High Yield Bonds Offer Investors?

Noted for a history of equity-like returns and less sensitivity to rising interest rates than investment grade bonds, high yield bonds have become known as a distinct asset class warranting a strategic allocation in many fixed income portfolios. Fallen angel bonds, high yield bonds that were originally investment grade issues, call for further distinction for an embedded value proposition that is not common to all of high yield.

Muni Bonds: Compelling Reasons to Invest

The often overlooked municipal marketplace is one that offers a variety of opportunities for investors, whether investors are looking to manage their interest rate risk or achieve higher returns in terms of yield.

Why India’s Generic Drug Growth Means a Big Opportunity

Over the years, India has become a leading pharmaceutical producer, with a fast growing generics and biosimilar market. India currently ranks fourth in the world among the highest generic pharmaceuticals producers and contributes 20% of global generic drug exports.

Rx for Growth? Why Generic Drugs Are Gaining Traction

A growing global population and an aging target demographic will likely drive continued demand for pharmaceuticals. Additionally, intensifying efforts to lower healthcare costs are expected to further buoy the generics industry.

Generics and Biosimilars – What Investors Need to Know

The global market for generics is significant—and it’s growing. The largest generic pharma companies earn a significant amount of their revenues from outside the United States. Plus, some companies are gaining global traction through partnerships and acquisitions abroad.

Expert Q&A: What to Know Before Investing in Generic Pharma?

Market Realist analysts recently conducted a Q&A with experts from VanEck on the generic pharmaceutical industry, a space that has attracted investor interest due to upside potential from brand name drugs coming off patent, cost saving pressure in the healthcare industry, and increased worldwide demand for prescription drugs.

Biosimilars: Why You Can Expect Opportunity Ahead

Generic drug manufacturers have recently moved into more complex products. One example is biosimilars, generic copies of molecularly complex biologic drugs. Biosimilars are beginning to take a foothold in the U.S. Importantly, they are much more difficult to replicate, than regular generics, which equates to high barriers to entry.

Drug Patent Expirations: $190 Billion Is Up for Grabs

Traditionally pharmaceutical companies undergo an expensive and time consuming process to develop new drugs. It often entails many years and millions of dollars in research and development, as well as an arduous approval process by the U.S. Food and Drug Administration (FDA).

Generics Keep Lowering Healthcare Costs: Opportunity Ahead?

Our population is aging and more people than ever are taking prescription drugs, contributing to the rising costs of health care. Consumers, insurance companies, and governments are all helping to fuel the growth of the generic drug industry by demanding lower-cost alternatives to brand name pharmaceuticals.


Please select a profession that best describes you: